Home › Geographic Atrophy › Illinois › Naperville
Geographic Atrophy clinical trials in Naperville, IL
6 studies for Geographic Atrophy are looking for participants at sites in and around Naperville (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)
RecruitingPhase 2
- University Retina, Lemont · 11 mi away
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
RecruitingPhase 1/2
- University Retina - Lemont- Site Number : 8400005, Lemont · 11 mi away
A Study in Adults With Geographic Atrophy
RecruitingPhase 2
- University Retina and Macula Associates, P.C., Lemont · 11 mi away
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RecruitingPhase 3
- University Retina and Macula Associates PC - Lemont, Lemont · 11 mi away
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RecruitingPhase 2/3
- University Retina, Lemont · 11 mi away
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Recruiting
- University Retina & Macula Associates, Lemont · 11 mi away
Geographic Atrophy trials in other cities
- Dallas, TX8 studies
- Reno, NV8 studies
- Santa Monica, CA7 studies
- Austin, TX7 studies
- Houston, TX6 studies
- Cleveland, OH6 studies
- Baltimore, MD6 studies
- The Woodlands, TX6 studies
- Erie, PA5 studies
- Hagerstown, MD5 studies
- San Antonio, TX5 studies
- Washington, DC5 studies
Other studies in Naperville
- Non-Small Cell Lung Cancer15 studies
- Heart Failure13 studies
- Lung Cancer13 studies
- Prostate Cancer10 studies
- Breast Cancer9 studies
- Cardiovascular Disease8 studies
- Macular Degeneration6 studies
- Cancer (all types)6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Pancreatic Cancer6 studies
- Melanoma5 studies
- Atrial Fibrillation5 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.